Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)

David Crossman, Alexander M K Rothman

Research output: Contribution to journalEditorialpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)S3084-S3087
JournalJournal of Thoracic Disease
Issue numberSuppl 26
Publication statusPublished - 18 Sept 2018

Cite this